Atlas Trials

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT06731413 · RECRUITING

Trial details

NCT number
NCT06731413
Sponsor
Virginia Commonwealth University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerNSCLCAdvanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Start date
2025-02-11
Primary completion
2030-07-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.